This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Headquartered in London, Aon plc is a British multinational corporation that offers risk management services, insurance and reinsurance brokerage, human resource consulting and outsourcing services worldwide. The company operates in more than 120 countries. As an insurance broker, Aon utilizes its resources to develop individual as well as group insurance programs. It offers its services globally across personal lines, mid-market companies and multinational companies.
AON's Rising Dividend: A Comforting Signal or Cause for Concern?
by Zacks Equity Research
AON announces a hike in the quarterly cash dividend to 74.5 cents per share.
Zacks Industry Outlook Erie Indemnity, Brown and Brown, Marsh & McLennan, Arthur J. Gallagher & Co and Aon
by Zacks Equity Research
Erie Indemnity, Brown and Brown, Marsh & McLennan, Arthur J. Gallagher & Co and Aon have been highlighted in this Industry Outlook article.
5 Stocks to Watch From the Thriving Insurance Brokerage Industry
by Sushmita Sarker
The increased demand for insurance products, strategic acquisitions and the adoption of technology are likely to drive the performance of Zacks Insurance Brokerage industry players like ERIE, BRO, MMC, AJG and AON.
Is the Options Market Predicting a Spike in AON Stock?
by Zacks Equity Research
Investors need to pay close attention to AON stock based on the movements in the options market lately.
Zacks Market Edge Highlights: Berkshire Hathaway, Aon plc and AbbVie
by Zacks Equity Research
Berkshire Hathaway, Aon plc and AbbVie are part of the Zacks Market Edge article.
3 Stocks Breaking Out Right Now
by Tracey Ryniec
Think every stock is selling off right now on tariff fears? Zacks Stock Strategist, Tracey Ryniec, shares a group of stocks bucking the trend.
eHealth Shares Down 3% Despite Q4 Earnings Beat, '25 View Unveiled
by Zacks Equity Research
EHTH's fourth-quarter results gain from higher approved members in Medicare Advantage and Medicare Part D plans. It expects 2025 revenues to be within $510-$550 million.
The Zacks Analyst Blog Highlights Broadcom, Thermo Fisher Scientific, Aon and Massimo
by Zacks Equity Research
Broadcom, Thermo Fisher Scientific, Aon and Massimo are included in this Analyst Blog.
Top Stock Reports for Broadcom, Thermo Fisher & Aon
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Thermo Fisher Scientific Inc. (TMO) and Aon plc (AON), as well as a micro-cap stock, Massimo Group (MAMO).
Allstate Q4 Earnings Beat on Strong Premium & Investment Income
by Zacks Equity Research
ALL agrees to divest the Group health business to Nationwide for $1.25 billion in cash.
Willis Towers Q4 Earnings Surpass Estimates on Higher Revenues
by Zacks Equity Research
WTW's Q4 results reflect higher revenues and expanded operating margins at the Health, Wealth & Career and Risk & Broking segments as well as lower expenses.
AON Q4 Earnings Surpass Estimates on New Business Growth
by Zacks Equity Research
Aon's Q4 results reflect strong organic growth and NFP acquisition synergies. However, rising costs weigh on margins.
Here's What Key Metrics Tell Us About Aon (AON) Q4 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Aon (AON) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Aon (AON) Tops Q4 Earnings Estimates
by Zacks Equity Research
Aon (AON) delivered earnings and revenue surprises of 4.25% and 1.06%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
5 Large-Cap Stocks Likely to Gain Post Earnings Release Tomorrow
by Nalak Das
Watch these five stocks on earnings results tomorrow: GWW, CHTR, AON, BR, CHD,
Can AON Beat Q4 Earnings on Commercial Risk Solutions Strength?
by Zacks Equity Research
AON's fourth-quarter results are likely to benefit from global expansion in the core health and benefits brokerage business.
Arthur J. Gallagher Set to Report Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
Better performances in both segments are likely to aid AJG's fourth-quarter results.
Aon (AON) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Aon (AON) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Investors Should Hold on to AON Stock Right Now
by Zacks Equity Research
Robust retention, new business and strategic acquisitions bode well for AON's growth.
Should You Buy, Sell or Hold Allstate Stock at a 10.23X P/E?
by Zacks Equity Research
Product improvements, expanding embedded protection plans and initiatives to improve retention bode well for ALL.
Top Research Reports for Amazon, Stryker & Lam Research
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Stryker Corporation (SYK) and Lam Research Corporation (LRCX), as well as a micro-cap stock, ImmuCell Corporation (ICCC).
Aon's Renewal of Aon Client Treaty Expands Insurance Capacity
by Zacks Equity Research
AON announces the renewal of its Client Treaty for 2025. Higher insurance capacity should help attract new clients.
AON Stock Rises 42.6% in Six Months: Get It or Let It Go?
by Zacks Equity Research
AON's expanding product portfolio and partnerships should aid its operations in the future.
eHealth Incurs Q3 Loss on Lower Commissions, Shares Down 6.1%
by Zacks Equity Research
EHTH's third-quarter results suffer from lower commissions and other revenues. Lower expenses partially offset the negatives.
Regional Management Shares Plunge 9.3% Despite Q3 Earnings Beat
by Zacks Equity Research
RM's third-quarter earnings benefit from rising interest and fee income and improved efficiency ratio. The hurricane impact, coupled with declining net insurance income, partially offset the results.